Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Goto

Showing results (41-50 of 265) with videos related to

Pageof 27
Sort By:
Journal of Atherosclerosis and Thrombosis|May 15, 2015
Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibα Measured by Atomic Force MicroscopyHiroaki Tobimatsu, Yuichiro Nishibuchi, Ryo Sudo, et al.
Polymers|March 29, 2023
Partial Miscibility and Concentration Distribution of Two-Phase Blends of Crosslinked NBR and PVCYuka Komori, Aoi Taniguchi, Haruhisa Shibata, et al.
Cardiology|February 2, 2013
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrelVictor L Serebruany, James J Dinicolantonio, Mehmet Mustafa Can, et al.
Circulation|July 10, 2002
Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditionsShinya Goto, Noriko Tamura, Shunnosuke Handa, et al.
European Heart Journal|September 1, 2010
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery diseaseShinya Goto, Hisao Ogawa, Masaru Takeuchi, et al.
Journal of Atherosclerosis and Thrombosis|February 4, 2010
Safety and exploratory efficacy of the novel thrombin receptor (PAR-1) antagonist SCH530348 for non-ST-segment elevation acute coronary syndromeShinya Goto, Tetsu Yamaguchi, Yasuo Ikeda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2002
Application of ex vivo flow chamber system for assessment of stent thrombosisMamoru Sakakibara, Shinya Goto, Koji Eto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 23, 2011
One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-Shinya Goto, Yasuo Ikeda, Kazuyuki Shimada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2015
Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO studyShinya Goto, Chien-Hua Huang, Seung-Jung Park, et al.
Masui. the Japanese Journal of Anesthesiology|May 18, 2012
[Anesthesia for a hemodialysis patient with HIT undergoing CABG using argatroban]Shinya Goto, Tomoko Hiramori, Kaori Kuroiwa, et al.
Pageof 27

Showing results (41-50 of 265) with videos related to

Sort By:
Pageof 27
Journal of Atherosclerosis and Thrombosis|May 15, 2015
Adhesive Forces between A1 Domain of von Willebrand Factor and N-terminus Domain of Glycoprotein Ibα Measured by Atomic Force MicroscopyHiroaki Tobimatsu, Yuichiro Nishibuchi, Ryo Sudo, et al.
Polymers|March 29, 2023
Partial Miscibility and Concentration Distribution of Two-Phase Blends of Crosslinked NBR and PVCYuka Komori, Aoi Taniguchi, Haruhisa Shibata, et al.
Cardiology|February 2, 2013
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrelVictor L Serebruany, James J Dinicolantonio, Mehmet Mustafa Can, et al.
Circulation|July 10, 2002
Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditionsShinya Goto, Noriko Tamura, Shunnosuke Handa, et al.
European Heart Journal|September 1, 2010
Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery diseaseShinya Goto, Hisao Ogawa, Masaru Takeuchi, et al.
Journal of Atherosclerosis and Thrombosis|February 4, 2010
Safety and exploratory efficacy of the novel thrombin receptor (PAR-1) antagonist SCH530348 for non-ST-segment elevation acute coronary syndromeShinya Goto, Tetsu Yamaguchi, Yasuo Ikeda, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2002
Application of ex vivo flow chamber system for assessment of stent thrombosisMamoru Sakakibara, Shinya Goto, Koji Eto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 23, 2011
One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. -Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE).-Shinya Goto, Yasuo Ikeda, Kazuyuki Shimada, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2015
Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome -- randomized, double-blind, phase III PHILO studyShinya Goto, Chien-Hua Huang, Seung-Jung Park, et al.
Masui. the Japanese Journal of Anesthesiology|May 18, 2012
[Anesthesia for a hemodialysis patient with HIT undergoing CABG using argatroban]Shinya Goto, Tomoko Hiramori, Kaori Kuroiwa, et al.
Pageof 27